Hummingbird Bioscience is based in Singapore, Singapore. It has raised $125M in total funding. Latest round: Series C.
Hummingbird Bioscience is based in Singapore, Singapore. Hummingbird Bioscience has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2021. The round record for Hummingbird Bioscience runs through 2021; nothing later has been disclosed. Investors on record include Novo Holdings, Frazier Healthcare Partners, Octagon Capital, EDBI, Amgen Ventures, DROIA Ventures and 10 others. 16 distinct backers are named across the disclosed rounds.
Totals shown for Hummingbird Bioscience aggregate every disclosed round on file. To see how that compares, browse the companies in Singapore and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026